| Literature DB >> 32675783 |
Thorvardur R Halfdanarson1, Jonathan R Strosberg2, Laura Tang3, Andrew M Bellizzi4, Emily K Bergsland5, Thomas M O'Dorisio6, Daniel M Halperin7, Lauren Fishbein8, Jennifer Eads9, Thomas A Hope10, Simron Singh11, Riad Salem12, David C Metz13, Boris G Naraev14, Diane L Reidy-Lagunes15, James R Howe16, Rodney F Pommier17, Yusuf Menda18, Jennifer A Chan19.
Abstract
This article is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management of pancreatic neuroendocrine tumors from July 19 to 20, 2018. The guidelines panel consisted of medical oncologists, pathologists, gastroenterologists, endocrinologists, and radiologists. The panel reviewed a series of questions regarding the medical management of patients with pancreatic neuroendocrine tumors as well as questions regarding surveillance after resection. The available literature was reviewed for each of the question and panel members voted on controversial topics, and the recommendations were included in a document circulated to all panel members for a final approval.Entities:
Mesh：
Year: 2020 PMID： 32675783 DOI： 10.1097/MPA.0000000000001597
Source DB: PubMed Journal: Pancreas ISSN： 0885-3177 Impact factor: 3.327